Nucleotide Oligomerization Domain 1 Ligation Suppressed Murine Allergen–Specific T-Cell Proliferation and Airway Hyperresponsiveness
Authors:
- 1 May 2014
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 50 (5) , 903-911
Abstract
The cytosolic nucleotide oligomerization domain (NOD)-like receptors NOD1 and NOD2 are important contributors to the intracellular recognition of pathogens including Chlamydophila pneumoniae, but little is known about their influence on allergen-induced airway inflammation. In BALB/c mice, we observed that infection with C. pneumoniae before systemic sensitization with ovalbumin (OVA) and local OVA airway exposure diminished airway hyperresponsiveness (AHR). Thus, the impact of the NOD1 agonist FK156 and the NOD2 agonist muramyl dipeptide given 6 hours before each sensitization or airway challenge was evaluated regarding AHR, OVA-specific plasma immunoglobulins, bronchoalveolar lavage fluid differentials, and cytokines. Spleen dendritic cells of FK156-treated mice were isolated and cocultured with OVA-specific T cells isolated from DO11.10 mice, and T-cell proliferation was quantified after OVA restimulation. T-cell proliferation was investigated in vivo in lungs and lymph nodes of FK156-treated and OVA-exposed DO11.10 mice. FK156, but not muramyl dipeptide, reduced AHR and pulmonary eosinophilic infiltration if given before OVA sensitization or challenge, whereas T-helper (Th)2 cytokines were not diminished. Dendritic cells from FK156-treated mice evoked less OVA-specific T-cell proliferation as compared with solvent-treated controls. Similarly, antigen-specific T-cell activation in lung tissue was diminished after FK156 treatment. We conclude that NOD1 activation reduced AHR in allergen-induced lung inflammation, which was accompanied by a reduction of allergen-specific T-cell proliferation.Keywords
This publication has 49 references indexed in Scilit:
- Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD MicePLOS ONE, 2010
- Innate Immune Recognition in Infectious and Noninfectious Diseases of the LungAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Progress in Allergy Signal Research on Mast Cells: Regulation of Allergic Airway Inflammation Through Toll-Like Receptor 4–Mediated Modification of Mast Cell FunctionJournal of Pharmacological Sciences, 2008
- Recognition of microorganisms and activation of the immune responseNature, 2007
- Lipopolysaccharide inhalation exacerbates allergic airway inflammation by activating mast cells and promoting Th2 responsesClinical & Experimental Allergy, 2006
- TLR4 Signaling Attenuates Ongoing Allergic InflammationThe Journal of Immunology, 2006
- TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathwayAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Cutting Edge: Activation of Toll-Like Receptor 2 Induces a Th2 Immune Response and Promotes Experimental AsthmaThe Journal of Immunology, 2004
- Inhibition of T helper 2‐type responses, IgE production and eosinophilia by synthetic lipopeptidesEuropean Journal of Immunology, 2003
- Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled AntigenJournal of Experimental Medicine, 2002